한국인 치과의사의 비스포스포네이트 관련 악골괴사에 대한 인식 연구 : 예비보고
AWARENESS OF KOREAN DENTISTS ON BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAWS : PRELIMINARY REPORT
0
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
Recently, an increasing number of bisphosphonate related osteonecrosis of the jaw(BRONJ) is being reported. A guideline has been already established in the US, but it does not seem to be fully recognized by clinicians in Korea. Therefore, a survey study was done to inform and have clinicians realize the seriousness of BRONJ. 1,341 practitioners were randomly selected out of 13,405 practitioners(by Feb of 2008, KDA) in Korea. A questionnaire was given to them between May to July in 2008. Questions were designed to investigate each respondent’s experience term years in the clinic, occupation, speciality, awareness on risk of bisphosphonate, experience on treating osteonecrosis patients, awareness about the guideline on BRONJ suggested by AAOMS and whether if they ask about bisphosphonate medication history to patients before invasive treatment. 45.1% of the clinicians have reported on experiencing delayed healing on bone exposed site after extraction both in the maxilla and the mandible. However, clinicians have asked the patients whether if they are on bisphosphonate or not in only 15.1% of these cases. 56.5% of the clinicians simply knew about BRONJ but only 28.9% of the clinicians were aware that bisphosphonate can cause osteonecrosis after invasive dental treatment. Only 19.3% knew about the contents of guideline on BRONJ and 57.2% were aware of the seriousness of BRONJ. Clinicians with shorter clinical experience term were more aware of BRONJ and the guideline on BRONJ than the experienced clinicians. But awareness of the possibility of BRONJ after invasive dental treatment were about the same regardless of their clinical experience. The results show that Korean clinicians need to be more aware about BRONJ. Data on BRONJ cases in Korea should be collected and provided with additional education to let Korean clinicians know and be more aware about BRONJ.
Abstract
Recently, an increasing number of bisphosphonate related osteonecrosis of the jaw(BRONJ) is being reported. A guideline has been already established in the US, but it does not seem to be fully recognized by clinicians in Korea. Therefore, a survey study was done to inform and have clinicians realize the seriousness of BRONJ. 1,341 practitioners were randomly selected out of 13,405 practitioners(by Feb of 2008, KDA) in Korea. A questionnaire was given to them between May to July in 2008. Questions were designed to investigate each respondent’s experience term years in the clinic, occupation, speciality, awareness on risk of bisphosphonate, experience on treating osteonecrosis patients, awareness about the guideline on BRONJ suggested by AAOMS and whether if they ask about bisphosphonate medication history to patients before invasive treatment. 45.1% of the clinicians have reported on experiencing delayed healing on bone exposed site after extraction both in the maxilla and the mandible. However, clinicians have asked the patients whether if they are on bisphosphonate or not in only 15.1% of these cases. 56.5% of the clinicians simply knew about BRONJ but only 28.9% of the clinicians were aware that bisphosphonate can cause osteonecrosis after invasive dental treatment. Only 19.3% knew about the contents of guideline on BRONJ and 57.2% were aware of the seriousness of BRONJ. Clinicians with shorter clinical experience term were more aware of BRONJ and the guideline on BRONJ than the experienced clinicians. But awareness of the possibility of BRONJ after invasive dental treatment were about the same regardless of their clinical experience. The results show that Korean clinicians need to be more aware about BRONJ. Data on BRONJ cases in Korea should be collected and provided with additional education to let Korean clinicians know and be more aware about BRONJ.
참고문헌 (18)
- "국민건강보험공단 2007통계연보, 대한민국, 2008", ~ (2008)
- Bize R, "Peytremann-Bridevaux I. Osteoporotic fracture in menopausal women: alendronate reduces the risk", Rev Med Suisse, 10(4), pp.2703~ (2008)
- Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaw : a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
- Dimitrakopoulos I, "Bisphos-phonateinduced avascular osteonecrosis of the jaws: a clinical report of 11 cases", Int J Oral Maxillofac Surg, 35, pp.588~593 (2006)
- Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates : a review of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
- Bagan JV, "Avascular jaw osteonecrosis in association with cancer chemotherapy : series of 10 cases", J Oral Pathol Med, 34, pp.120~123 (2005)
- "2006 position paper on Bisphosphonate-related osteonecrosis of the jaw"[URL]
- 권용대, "Bisphosphonate, 구강악안면외과 영역의 새로운 위험 요소인가?", 대한악안면성형재건외과학회지, 29(5), pp.456~462 (2007), 대한악안면성형재건외과학회
- Haderslev KV, "Sorensen HA et al. Alendronate increases lumbar spine bone mineral density in patients with Crohn’s disease", Gastroenterology, 119, pp.639~646 (2000)
- "American’s Bone Health"[URL]
- Gr¨otz KA, "Zahn¨arztliche Betreuung von Patienten mit tumortherapeutischer Kopf-Hals-Bestrahlung (Stellungnahme der DGZMK und DEGRO)", Dtsch Zahn¨arztl Z, 57, pp.509~ (2002)
- Hansen T, "Osteonecrosis of the jaws in patients treated with bisphosphonates- histomorphologic analysis in comparison with infected osteoradionecrosis", J Oral Pathol Med, 35, pp.155~160 (2006)
- Altundag K, "Tooth extraction : Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?", J Oral Maxillofac Surg, 65, pp.154~ (2007)
- Groetz KA, "Persisting alveolar sockets-a radiologic symptom of BP-ONJ", J Oral Maxillofac Surg, 64, pp.1571~1572 (2006)
- Schilling J, "Management of bisphosphonate-induced osteonecrosis of the jaw", Northwest Dent, 87, pp.34~35 (2008)
- Black DM, "Boonen S, Cauley JA et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis", N Eng1 J Med, 356, pp.1809~1822 (2007)
- Walter C, "Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis", Support Care Cancer, 15, pp.197~202 (2007)